ArticleCureus2026
Granulomatosis With Polyangiitis Unmasked by COVID-19 Infection: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulomatosis with polyangiitis (GPA) is a type of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), in which small- to medium-sized vessels are targeted. The incidence increases with age, and the most commonly affected systems include the sinonasal tract, lungs, and kidneys. Etiology remains unclear, although exposure to environmental triggers, including infections, has been hypothesized to initiate or unmask autoimmunity in genetically predisposed individuals. The nasal microbiome is also hypothesized to play a role in the disease process, although research is still ongoing. In this report, we present a case of a 65-year-old female with a long history of nonspecific musculoskeletal, sinus, and gastrointestinal complaints, who developed multifocal pneumonia with hemoptysis and progressive pulmonary disease shortly after COVID-19 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.